Compare PTGX & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | TSLX |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | 141 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 1.8B |
| IPO Year | 2016 | 2011 |
| Metric | PTGX | TSLX |
|---|---|---|
| Price | $136.76 | $18.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $108.23 | $21.61 |
| AVG Volume (30 Days) | ★ 526.9K | 379.8K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 10.82% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.35 | 0.15 |
| Revenue | N/A | N/A |
| Revenue This Year | $874.25 | N/A |
| Revenue Next Year | N/A | $1.20 |
| P/E Ratio | ★ $58.44 | $121.00 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $62.24 | $16.04 |
| 52 Week High | $160.81 | $23.19 |
| Indicator | PTGX | TSLX |
|---|---|---|
| Relative Strength Index (RSI) | 40.35 | 52.24 |
| Support Level | $130.63 | $17.20 |
| Resistance Level | $142.20 | $18.59 |
| Average True Range (ATR) | 4.74 | 0.32 |
| MACD | -0.99 | 0.01 |
| Stochastic Oscillator | 12.72 | 75.00 |
Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.
Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.